225 related articles for article (PubMed ID: 35485685)
1. Tumor Infiltrating Lymphocytes are Prognostic Factors and Can Be Markers of Sensitivity to Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma.
Suzuki H; Kawasaki Y; Miura M; Hatakeyama H; Shina K; Suzuki S; Yamada T; Suzuki M; Ito A; Omori Y
Asian Pac J Cancer Prev; 2022 Apr; 23(4):1271-1278. PubMed ID: 35485685
[TBL] [Abstract][Full Text] [Related]
2. Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer.
Balermpas P; Michel Y; Wagenblast J; Seitz O; Weiss C; Rödel F; Rödel C; Fokas E
Br J Cancer; 2014 Jan; 110(2):501-9. PubMed ID: 24129245
[TBL] [Abstract][Full Text] [Related]
3. Overall assessment of tumor-infiltrating lymphocytes in head and neck squamous cell carcinoma: time to take notice.
Almangush A; Leivo I; Mäkitie AA
Acta Otolaryngol; 2020 Mar; 140(3):246-248. PubMed ID: 32022615
[No Abstract] [Full Text] [Related]
4. Prognostic value of Hematoxylin and eosin staining tumor-infiltrating lymphocytes (H&E-TILs) in patients with esophageal squamous cell carcinoma treated with chemoradiotherapy.
Zheng J; Zhang H; Li S; Kang Z; Zheng F; Yao Q; Zhang X; Wu Z; Wang J; Fang W; Li J; Chen G; Chen Y; Chen M
BMC Cancer; 2023 Dec; 23(1):1193. PubMed ID: 38053017
[TBL] [Abstract][Full Text] [Related]
5. Prognostic and Predictive Relevance of Tumor-Infiltrating Lymphocytes in Squamous Cell Head-Neck Cancer Patients Treated with Radical Radiotherapy/Chemo-Radiotherapy.
Koukourakis IM; Gkegka AG; Xanthopoulou E; Nanos C; Giatromanolaki A; Koukourakis MI
Curr Oncol; 2022 Jun; 29(6):4274-4284. PubMed ID: 35735451
[TBL] [Abstract][Full Text] [Related]
6. Digital pathology-aided assessment of tumor-infiltrating T lymphocytes in advanced stage, HPV-negative head and neck tumors.
de Ruiter EJ; de Roest RH; Brakenhoff RH; Leemans CR; de Bree R; Terhaard CHJ; Willems SM
Cancer Immunol Immunother; 2020 Apr; 69(4):581-591. PubMed ID: 31980916
[TBL] [Abstract][Full Text] [Related]
7. Tumor-infiltrating lymphocytes in oral cavity squamous cell carcinoma and its association with clinicopathological parameters.
Ahuja S; Khan AA; Zaheer S; Ranga S
Pathol Res Pract; 2023 Nov; 251():154882. PubMed ID: 37898039
[TBL] [Abstract][Full Text] [Related]
8. A digital score of tumour-associated stroma infiltrating lymphocytes predicts survival in head and neck squamous cell carcinoma.
Shaban M; Raza SEA; Hassan M; Jamshed A; Mushtaq S; Loya A; Batis N; Brooks J; Nankivell P; Sharma N; Robinson M; Mehanna H; Khurram SA; Rajpoot N
J Pathol; 2022 Feb; 256(2):174-185. PubMed ID: 34698394
[TBL] [Abstract][Full Text] [Related]
9. Assessing the prognostic value of tumor-infiltrating CD57+ cells in advanced stage head and neck cancer using QuPath digital image analysis.
de Ruiter EJ; Bisheshar SK; de Roest RH; Wesseling FWR; Hoebers FJP; van den Hout MFCM; Leemans CR; Brakenhoff RH; de Bree R; Terhaard CHJ; Willems SM
Virchows Arch; 2022 Aug; 481(2):223-231. PubMed ID: 35451620
[TBL] [Abstract][Full Text] [Related]
10. CD8+ tumour-infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy: A multicentre study of the German cancer consortium radiation oncology group (DKTK-ROG).
Balermpas P; Rödel F; Rödel C; Krause M; Linge A; Lohaus F; Baumann M; Tinhofer I; Budach V; Gkika E; Stuschke M; Avlar M; Grosu AL; Abdollahi A; Debus J; Bayer C; Stangl S; Belka C; Pigorsch S; Multhoff G; Combs SE; Mönnich D; Zips D; Fokas E
Int J Cancer; 2016 Jan; 138(1):171-81. PubMed ID: 26178914
[TBL] [Abstract][Full Text] [Related]
11. Novel pathological predictive factors for extranodal extension in oral squamous cell carcinoma: a retrospective cohort study based on tumor budding, desmoplastic reaction, tumor-infiltrating lymphocytes, and depth of invasion.
Noda Y; Ishida M; Ueno Y; Fujisawa T; Iwai H; Tsuta K
BMC Cancer; 2022 Apr; 22(1):402. PubMed ID: 35418058
[TBL] [Abstract][Full Text] [Related]
12. Tumor infiltrating lymphocytes and survival in patients with head and neck squamous cell carcinoma.
Nguyen N; Bellile E; Thomas D; McHugh J; Rozek L; Virani S; Peterson L; Carey TE; Walline H; Moyer J; Spector M; Perim D; Prince M; McLean S; Bradford CR; Taylor JM; Wolf GT;
Head Neck; 2016 Jul; 38(7):1074-84. PubMed ID: 26879675
[TBL] [Abstract][Full Text] [Related]
13. Prognostic and predictive values of immune infiltrate in patients with head and neck squamous cell carcinoma.
Zhang XM; Song LJ; Shen J; Yue H; Han YQ; Yang CL; Liu SY; Deng JW; Jiang Y; Fu GH; Shen WW
Hum Pathol; 2018 Dec; 82():104-112. PubMed ID: 30036594
[TBL] [Abstract][Full Text] [Related]
14. Characteristics and impact of programmed death-ligand 1 expression, CD8+ tumor-infiltrating lymphocytes, and p16 status in head and neck squamous cell carcinoma.
Ngamphaiboon N; Chureemas T; Siripoon T; Arsa L; Trachu N; Jiarpinitnun C; Pattaranutaporn P; Sirachainan E; Larbcharoensub N
Med Oncol; 2019 Jan; 36(2):21. PubMed ID: 30666437
[TBL] [Abstract][Full Text] [Related]
15. Method for estimation of apoptotic cell fraction of cytotherapy using in vivo fluorine-19 magnetic resonance: pilot study in a patient with head and neck carcinoma receiving tumor-infiltrating lymphocytes labeled with perfluorocarbon nanoemulsion.
Ahrens ET; Helfer BM; O'Hanlon CF; Lister DR; Bykowski JL; Messer K; Leach BI; Chen J; Xu H; Daniels GA; Cohen EEW
J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37339797
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of pathological complete remission after preoperative irradiation in patients with locally advanced head and neck squamous cell carcinoma: re-analysis of a phase 3 clinical study.
Wang K; Yi J; Huang X; Qu Y; Luo J; Xiao J; Zhang S; Tang Y; Liu W; Xu G; Gao L; Xu Z; Liu S; Wang X
Radiat Oncol; 2019 Dec; 14(1):225. PubMed ID: 31831042
[TBL] [Abstract][Full Text] [Related]
17. Ovarian cancer-derived copy number alterations signatures are prognostic in chemoradiotherapy-treated head and neck squamous cell carcinoma.
Essers PBM; van der Heijden M; Vossen D; de Roest RH; Leemans CR; Brakenhoff RH; van den Brekel MWM; Bartelink H; Verheij M; Vens C
Int J Cancer; 2020 Sep; 147(6):1732-1739. PubMed ID: 32167160
[TBL] [Abstract][Full Text] [Related]
18. High neutrophil-to-lymphocyte ratio predicts poor prognosis in patients with squamous cell carcinoma of the head and neck treated with definitive chemoradiotherapy.
Chandrasekara S; Davis S; Thomson P; Haydon A
Asia Pac J Clin Oncol; 2018 Oct; 14(5):e442-e447. PubMed ID: 29345108
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of tumor-infiltrating immune cells and immune checkpoints in elderly head-and-neck squamous cell carcinoma patients undergoing definitive (chemo)radiotherapy.
Rühle A; Todorovic J; Spohn SSK; Gkika E; Becker C; Knopf A; Zamboglou C; Sprave T; Werner M; Grosu AL; Kayser G; Nicolay NH
Radiat Oncol; 2022 Nov; 17(1):181. PubMed ID: 36376922
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of nutritional and hematologic markers in head and neck squamous cell carcinoma treated by chemoradiotherapy.
Moon H; Roh JL; Lee SW; Kim SB; Choi SH; Nam SY; Kim SY
Radiother Oncol; 2016 Feb; 118(2):330-4. PubMed ID: 26653356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
